Aquatic Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-162,030
Closed -$3.02M 1674
2025
Q2
$3.02M Buy
162,030
+139,382
+615% +$2.76M 0.06% 361
2025
Q1
$434K Buy
22,648
+1,402
+7% +$41K 0.01% 783
2024
Q4
$765K Sell
21,246
-46,254
-69% -$1.56M 0.02% 618
2024
Q3
$2.86M Buy
67,500
+17,747
+36% +$752K 0.07% 292
2024
Q2
$2M Buy
+49,753
New +$2.08M 0.07% 266
2023
Q3
Sell
-3,900
Closed -$96K 1655
2023
Q2
$96K Buy
3,900
+2,000
+105% +$64.3K 0.01% 863
2023
Q1
$77K Sell
1,900
-5,400
-74% -$224K ﹤0.01% 806
2022
Q4
$328K Buy
+7,300
New +$330K 0.02% 615
2022
Q3
Sell
-3,000
Closed -$178K 1549
2022
Q2
$178K Buy
+3,000
New +$246K 0.06% 365

Other funds holding TNDM

Aquatic Capital Management's TNDM Position: Q3 2025 in Review

Aquatic Capital Management sold out of Tandem Diabetes Care (TNDM) in Q3 2025, closing a stake of 162,030 shares — an estimated $3.02M sold.

Aquatic Capital Management first reported a position in TNDM in Q2 2022 and held it in 9 quarters. The position peaked at $3.02M in Q2 2025. 255 funds tracked by Wall St. Rank hold TNDM as of Q3 2025.

  • Aquatic Capital Management reported no remaining Tandem Diabetes Care position as of Q3 2025 after selling out during the quarter.
  • Aquatic Capital Management sold 162,030 Tandem Diabetes Care shares in Q3 2025, an estimated $3.02M.
  • Aquatic Capital Management first reported a position in Tandem Diabetes Care in Q2 2022 and held it in 9 quarters.
  • Aquatic Capital Management's Tandem Diabetes Care position peaked at $3.02M in Q2 2025.
  • 255 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2025.

Based on Aquatic Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.